Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1365709
                    [Title] => FDA OKs Merck drug, 1st in new cancer drug class
                    [Summary] => 
U.S. regulators have approved the first drug in a new class of cancer medicines that work by stimulating the immune system, a Merck drug developed for treating deadly skin cancer.

                    [DatePublished] => 2014-09-05 05:14:17
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

RIVAL BRISTOL-MYERS SQUIBB

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1365709
                    [Title] => FDA OKs Merck drug, 1st in new cancer drug class
                    [Summary] => 
U.S. regulators have approved the first drug in a new class of cancer medicines that work by stimulating the immune system, a Merck drug developed for treating deadly skin cancer.

                    [DatePublished] => 2014-09-05 05:14:17
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

abtest

FDA OKs Merck drug, 1st in new cancer drug class

September 5, 2014 - 5:14am

U.S. regulators have approved the first drug in a new class of cancer medicines that work by stimulating the immune system, a Merck drug developed for treating deadly skin cancer.

Health And Family